BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24850028)

  • 1. Comparison of 2 oral ultrasonography contrast agents: simethicone-coated cellulose and simethicone-water rotation in improving pancreatic visualization.
    Ishigami K; Abu-Yousef DM; Kao SC; Abu-Yousef MM
    Ultrasound Q; 2014 Jun; 30(2):135-8. PubMed ID: 24850028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved US visualization of the pancreatic tail with simethicone, water, and patient rotation.
    Abu-Yousef MM; El-Zein Y
    Radiology; 2000 Dec; 217(3):780-5. PubMed ID: 11110943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of simethicone-coated cellulose as a negative oral contrast agent for abdominal CT.
    Sahani DV; Jhaveri KS; D'souza RV; Varghese JC; Halpern E; Harisinghani MG; Hahn PF; Saini S
    Acad Radiol; 2003 May; 10(5):491-6. PubMed ID: 12755536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Predictive of Improved Abdominal Ultrasound Visualization after Oral Administration of Simethicone.
    Marsico M; Gabbani T; Casseri T; Biagini MR
    Ultrasound Med Biol; 2016 Nov; 42(11):2532-2537. PubMed ID: 27481017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound contrast. Oral and i.v. agents amplify the image.
    Barr RG
    Diagn Imaging (San Franc); 1999 Mar; 21(3):56-61. PubMed ID: 10351114
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of a new oral contrast agent for sonography: a phase II trial.
    Lev-Toaff AS; Langer JE; Rubin DL; Zelch JV; Chong WK; Barone AE; Goldberg BB
    AJR Am J Roentgenol; 1999 Aug; 173(2):431-6. PubMed ID: 10430149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simethicone coated cellulose as an oral contrast agent for ultrasound of the upper abdomen.
    Harisinghani MG; Saini S; Schima W; McNicholas M; Mueller PR
    Clin Radiol; 1997 Mar; 52(3):224-6. PubMed ID: 9091258
    [No Abstract]   [Full Text] [Related]  

  • 8. Own observations on the use of Esputicon to eliminate gases from the pancreatic area during ultrasound examinations.
    Jedrzejewski G; Złomaniec J
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():123-7. PubMed ID: 11205751
    [No Abstract]   [Full Text] [Related]  

  • 9. Simethicone coated cellulose as an oral contrast agent for ultrasound of the upper abdomen.
    Stewart I; Cooke P
    Clin Radiol; 1998 Mar; 53(3):234. PubMed ID: 9528881
    [No Abstract]   [Full Text] [Related]  

  • 10. Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial.
    Elvas L; Areia M; Brito D; Alves S; Saraiva S; Cadime AT
    Endoscopy; 2017 Feb; 49(2):139-145. PubMed ID: 27852098
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of clebopride-simethicone combination therapy on echographic visualization of retrogastric organs.
    Herrerías Gutiérrez JM; García Montes J
    Clin Ther; 1994; 16(3):483-9. PubMed ID: 7923315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal pain.
    Bree RL; Arnold RJ; Pettit KG; Kaniecki DJ; O'haeri C; LaFrance ND; Toaff AL
    Acad Radiol; 2001 Mar; 8(3):234-42. PubMed ID: 11249087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy.
    Chang WK; Yeh MK; Hsu HC; Chen HW; Hu MK
    J Gastroenterol Hepatol; 2014 Apr; 29(4):769-74. PubMed ID: 24325147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of simethicone coated cellulose (SonoRx) as a negative oral contrast agent for abdominal-pelvic computed tomography.
    Saini S; Jhaveri KS; Sahani DV; Varghese JC; Hahn PF
    Acad Radiol; 2002 Aug; 9 Suppl 2():S357-8. PubMed ID: 12188274
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cellulose concentration on the efficacy of a cellulose-based oral contrast agent for gastrointestinal ultrasonography.
    Sisler WJ; Tilcock C
    J Ultrasound Med; 1995 Apr; 14(4):267-72. PubMed ID: 7602683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of simethicone and fasting on the quality of abdominal ultrasonography in New Zealand White rabbits.
    da Silva KG; de Andrade C; Sotomaior CS
    Acta Vet Scand; 2017 Jul; 59(1):48. PubMed ID: 28716083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved image quality during abdominal ultrasonography by clebopride + simethicone.
    Varas MJ; López A
    Methods Find Exp Clin Pharmacol; 1991; 13(1):69-72. PubMed ID: 1870360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
    Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
    Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double contrast-enhanced ultrasound improves the detection and localization of occult lesions in the pancreatic tail: a initial experience report.
    Zhu W; Mai G; Zhou X; Song B
    Abdom Radiol (NY); 2019 Feb; 44(2):559-567. PubMed ID: 30121778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.